New York, May 28, 2026, 14:03 EDT
- NTWO last traded at $10.64. Only 112 shares changed hands. The stock’s 52-week range is $10.18 to $10.64.
- As of March 31, the SPAC held $183.4 million in its trust, or $10.63 per redeemable Class A share.
- Newbury has until Nov. 4, 2026 to finish a merger or else must redeem its public shares and shut down.
Newbury Street II Acquisition Corp traded close to a 52-week high Thursday, with shares barely moving. The calm session mostly stemmed from the SPAC’s cash-heavy setup, not any new buying interest.
NTWO Class A shares on Nasdaq last traded at $10.64, matching the session high, low and open. Only 112 shares changed hands, well under the 11,310 average on Robinhood. The company had a market cap near $256.6 million, according to .
This is in focus now since Newbury is a SPAC, or special purpose acquisition company. It’s a listed shell that raises funds and then searches for a private firm to merge with. With no target yet, trading usually stays near the cash value in trust—the amount earmarked for a deal or to pay out shareholders who want out.
Newbury reported in its May 12 quarterly filing it had $183.4 million in trust as of March 31, or $10.63 per redeemable Class A share. The company also said it hadn’t yet reached a definitive deal with any business-combination target.
Stocks moved up on the broader U.S. tape. The S&P 500 and Nasdaq pushed higher earlier Thursday after a report flagged progress on a possible U.S.-Iran deal. Traders kept inflation worries in mind. “Traders were on a hair trigger around deal headlines,” Jamie Cox, managing partner at Harris Financial Group, told Reuters. Reuters
NTWO traded with barely a penny separating its last quote from the March-end redemption value. That slim gap doesn’t offer much suggestion that traders are wagering on a hefty merger premium here.
Newbury showed first-quarter net income of $1.39 million, off from $1.69 million a year ago, according to S&P Capital IQ via MarketScreener. The results matched what’s common for a SPAC before merging.
NewHold Investment Corp III, a SPAC, said it will take nuclear startup Newcleo public in a deal giving Newcleo a $2.4 billion valuation before new funds. Newcleo CEO Stefano Buono said a listing would let the company “rapidly advance” its reactor and fuel-manufacturing push. Reuters
That’s the split. NewHold has a target, but Newbury hasn’t named one in a binding deal.
NTWO’s main risk is structural. Newbury has to finish a business combination by Nov. 4, 2026, or it will have to redeem public shares and liquidate. Its filing said that deadline puts big doubt on its ability to keep going as a standalone company, with management noting the uncertainty. If no deal happens, its warrants expire worthless.
The next move is hard to call. It could be a target deal, maybe an extension proposal, or maybe the SPAC just lets the clock run out. For now, this stock isn’t trading on earnings talk—it’s acting more like a trust-value play with an end date hanging over it.
